Enveda Biosciences logo

Enveda Biosciences Funding & Investors

Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle todayโ€™s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. Enveda, launched in 2019, is based in San Francisco, California.

envedabio.com

Total Amount Raised: $229,900,000

Enveda Biosciences Funding Rounds

  • Series B

    $55,000,000

    Series B Investors

    Lingotto
    True Ventures
    Microsoft
    FPV Ventures
    Level Ventures
    PremjiInvest
    Jazz Venture Partners
    The Nature Conservancy
    Kinnevik
  • Series B

    $51,000,000

    Series B Investors

    Kinnevik
    True Ventures
    Wireframe Ventures
    FPV Ventures
    Dimension
    Henry Kravis
  • Debt Financing

    $13,000,000

    Debt Financing Investors

    Silicon Valley Bank
  • Series B

    $55,000,000

    Series B Investors

    Dimension
    FPV Ventures
    Jazz Venture Partners
    Amino Collective
    True Ventures
    Allen & Company
    Level Ventures
    Lux Capital
    Possible Ventures
    Hummingbird Ventures
    Wireframe Ventures
    Two Sigma Ventures
  • Seed

    $4,900,000

    Seed Investors

    True Ventures
    Village Global
    Chris Gibson
    Wireframe Ventures
  • Series A

    $51,000,000

    Series A Investors

    Lux Capital
    Catalio Capital Management
    Wireframe Ventures
    True Ventures
    Hummingbird Ventures
    Chris Gibson
    Lifeforce Capital
    Two Sigma Ventures
    Village Global
    Matt De Silva
    Bioverge
Funding info provided by Diffbot.